Stacey Seltzer

Stacey Seltzer is a Managing Partner at Pontiva and a Partner at Gurnet Point Capital, based in Cambridge, Massachusetts. Before joining Gurnet Point in 2022, she served as a Partner at Aisling Capital, where she led or co-led more than 15 transactions involving growth-stage life science companies. Earlier in her career, Seltzer worked at Schering-Plough in business development and sales, serving as the U.S. Brand Lead for Zetia and negotiating deals with aggregate values exceeding one billion dollars. She currently sits on the board of directors for NASDAQ-listed Reneo Pharmaceuticals and holds advisory roles with the Blavatnik Fund for Innovation at Yale University, where she previously earned her undergraduate and graduate degrees in molecular biophysics and biochemistry. Her current investment strategy focuses on sourcing and scaling growth-stage therapeutics and biotechnology companies across the broader healthcare sector.